Perspective Therapeutics (CATX) Total Liabilities (2011 - 2026)
Perspective Therapeutics (CATX) posted Total Liabilities of $63.3 million for Q1 2026, up 5.66% sequentially from $59.9 million in Q4 2025, and up 41.67% YoY from $44.7 million in Q1 2025.
Perspective Therapeutics (CATX) Total Liabilities (2011 - 2026) Analysis & Trends
Perspective Therapeutics has reported Total Liabilities for 16 years, with the latest figure at $63.3 million in Q1 2026.
- Quarterly Total Liabilities rose 41.67% year-over-year to $63.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.3 million (up 41.67% YoY) and the FY2025 annual result came in at $59.9 million, up 18.85% from the prior year.
- Total Liabilities rose to $63.3 million in Q1 2026 per CATX's latest filing, from $59.9 million in the prior quarter.
- Over five years, Total Liabilities peaked at $63.3 million in Q1 2026 and troughed at $2.9 million in Q1 2022.
- A 5-year average of $31.9 million and a median of $44.7 million in 2025 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2023 and 2025: Total Liabilities surged 558.51% in 2023, then fell 16.07% in 2025.
- Over 5 years, Total Liabilities stood at $3.4 million in 2022, then soared by 558.51% to $22.7 million in 2023, then surged by 122.05% to $50.4 million in 2024, then advanced by 18.85% to $59.9 million in 2025, then gained by 5.66% to $63.3 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $63.3 million, $59.9 million, and $52.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.23 Bn | 196.63 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 127.28 Bn | 123.80 Bn | 4.50 Bn | 23.94 Bn |
| 3 | Medtronic | 119.00 Bn | 109.78 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 74.41 Bn | 73.88 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.77 Bn | 47.52 Bn | 1.35 Bn | 3.14 Bn |
| 6 | Dexcom | 35.03 Bn | 33.09 Bn | 830.00 Mn | 3.83 Bn |
| 7 | GE HealthCare Technologies | 33.80 Bn | 31.69 Bn | 2.18 Bn | 26.03 Bn |
| 8 | Koninklijke Philips | 26.24 Bn | 22.92 Bn | 4.55 Bn | 17.70 Bn |
| 9 | Steris | 23.20 Bn | 22.71 Bn | 684.20 Mn | 3.51 Bn |
| 10 | Perspective Therapeutics | 401.16 Mn | 401.16 Mn | - | 68.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 68.16 Mn |
| Mar 31, 2026 | 63.33 Mn |
| Dec 31, 2025 | 59.94 Mn |
| Sep 30, 2025 | 52.61 Mn |
| Jun 30, 2025 | 45.03 Mn |
| Mar 31, 2025 | 44.70 Mn |
| Dec 31, 2024 | 50.43 Mn |
| Sep 30, 2024 | 62.68 Mn |
| Jun 30, 2024 | 44.92 Mn |
| Mar 31, 2024 | 48.40 Mn |
| Dec 31, 2023 | 22.71 Mn |
| Sep 30, 2023 | 11.75 Mn |
| Jun 30, 2023 | 11.49 Mn |
| Mar 31, 2023 | 9.62 Mn |
| Dec 31, 2022 | 3.45 Mn |
| Sep 30, 2022 | 4.84 Mn |
| Jun 30, 2022 | 3.16 Mn |
| Mar 31, 2022 | 2.91 Mn |
| Dec 31, 2021 | 2.86 Mn |
| Sep 30, 2021 | 2.95 Mn |